Streetbeat News

Price Targets

ARWR

Piper Sandler analyst Edward Tenthoff has reiterated an Overweight rating on Arrowhead Pharma (NASDAQ:ARWR) and maintained a price target of $62.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 2:36 pm

NDAQ

RBC Capital has reiterated its Outperform rating on Nasdaq (NDAQ) and maintained a price target of $88.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 2:35 pm

PRCT

Piper Sandler analyst Matt O'Brien has reiterated an Overweight rating on PROCEPT BioRobotics (NASDAQ:PRCT) and maintained a price target of $75.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 2:35 pm

NBIX

RBC Capital analyst Brian Abrahams has reiterated a Sector Perform rating on Neurocrine Biosciences (NASDAQ:NBIX) and maintained a price target of $133.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 2:31 pm

PANW

Investors are showing a bearish sentiment towards Palo Alto Networks (PANW) in the options market, with a significant number of large trades observed. The sentiment is split, with 38% bullish and 42% bearish. The stock is currently up 4.61% at $353.53, and analysts have a consensus target price of $425. Goldman Sachs maintains a Buy rating.

Portfolio Pulse from Benzinga Insights

October 08, 2024 | 2:31 pm

AVGO

Truist Securities has maintained its Buy rating on Broadcom (NASDAQ:AVGO) and slightly increased the price target from $204 to $205.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 2:28 pm

B

Truist Securities has maintained a Hold rating on Barnes Group (NYSE:B) while raising the price target from $38 to $47.5.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 2:26 pm

RLI

RBC Capital has reiterated a Sector Perform rating for RLI Corp with a maintained price target of $162.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 2:25 pm

SM

RBC Capital has reiterated a Sector Perform rating for SM Energy, maintaining a price target of $50.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 2:23 pm

RIVN

Goldman Sachs analyst Mark Delaney has maintained a Neutral rating on Rivian Automotive (NASDAQ:RIVN) but has lowered the price target from $13 to $11.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 2:23 pm